These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 7977117)

  • 1. The effect of probucol on femoral atherosclerosis: the Probucol Quantitative Regression Swedish Trial (PQRST).
    Walldius G; Erikson U; Olsson AG; Bergstrand L; Hådell K; Johansson J; Kaijser L; Lassvik C; Mölgaard J; Nilsson S
    Am J Cardiol; 1994 Nov; 74(9):875-83. PubMed ID: 7977117
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lowering of HDL2b by probucol partly explains the failure of the drug to affect femoral atherosclerosis in subjects with hypercholesterolemia. A Probucol Quantitative Regression Swedish Trial (PQRST) Report.
    Johansson J; Olsson AG; Bergstrand L; Elinder LS; Nilsson S; Erikson U; Mölgaard J; Holme I; Walldius G
    Arterioscler Thromb Vasc Biol; 1995 Aug; 15(8):1049-56. PubMed ID: 7627695
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of femoral atherosclerosis in hypercholesterolemic patients during treatment with cholestyramine and probucol/placebo: Probucol Quantitative Regression Swedish Trial (PQRST): a status report.
    Walldius G; Carlson LA; Erikson U; Olsson AG; Johansson J; Mölgaard J; Nilsson S; Stenport G; Kaijser L; Lassvik C
    Am J Cardiol; 1988 Jul; 62(3):37B-43B. PubMed ID: 3293415
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of probucol on low density lipoprotein oxidation and femoral atherosclerosis.
    Regnström J; Walldius G; Nilsson S; Elinder LS; Johansson J; Mölgaard J; Holme I; Olsson AG; Nilsson J
    Atherosclerosis; 1996 Sep; 125(2):217-29. PubMed ID: 8842353
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of lipids and antioxidative factors for development of atherosclerosis. The Probucol Quantitative Regression Swedish Trial (PQRST).
    Walldius G; Regnström J; Nilsson J; Johansson J; Schäfer-Elinder L; Moelgaard J; Hådell K; Olsson AG; Carlson LA
    Am J Cardiol; 1993 Feb; 71(6):15B-19B. PubMed ID: 8434556
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Probucol and cholestyramine combination in the treatment of severe hypercholesterolemia.
    Sommariva D; Bonfiglioli D; Tirrito M; Pogliaghi I; Branchi A; Cabrini E
    Int J Clin Pharmacol Ther Toxicol; 1986 Sep; 24(9):505-10. PubMed ID: 3781686
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Probucol Quantitative Regression Swedish Trial: new angiographic technique to measure atheroma volume of the femoral artery.
    Erikson U; Nilsson S; Stenport G
    Am J Cardiol; 1988 Jul; 62(3):44B-47B. PubMed ID: 3293416
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Femoral and coronary atherosclerosis in patients with hyperlipidaemia. Arteriographic findings correlated to clinical and biochemical parameters.
    Bergstrand L
    Acta Radiol Suppl; 1994; 392():1-27. PubMed ID: 8184697
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical evaluation of probucol in hypercholesteremia: individual lipoprotein responses and inhibitory effect on carotid atherosclerosis progression.
    Baldassarre D; Franceschini G; Peruzzotti G; Brusoni B; Sirtori CR
    J Cardiovasc Pharmacol; 1997 Dec; 30(6):784-9. PubMed ID: 9436818
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reproducibility of quantitative arteriographic assessment of atherosclerosis in the femoral artery.
    Bergstrand L; Erikson U; Holme I; Johansson J; Olsson AG; Mølgaard J; Nilsson S; Stenport G; Walldius G
    Acta Radiol; 1993 Nov; 34(6):612-7. PubMed ID: 8240898
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of probucol treatment on the susceptibility of low density lipoprotein isolated from hypercholesterolemic patients to become oxidatively modified in vitro.
    Regnström J; Walldius G; Carlson LA; Nilsson J
    Atherosclerosis; 1990 May; 82(1-2):43-51. PubMed ID: 2360919
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of probucol on xanthomata regression in familial hypercholesterolemia.
    Yamamoto A; Matsuzawa Y; Yokoyama S; Funahashi T; Yamamura T; Kishino B
    Am J Cardiol; 1986 Jun; 57(16):29H-35H. PubMed ID: 3728307
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Changes in atheroma volume estimated from digitized femoral arteriograms.
    Nilsson S; Erikson U
    Acta Radiol; 1990 May; 31(3):249-57. PubMed ID: 2201327
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative efficacy and safety of pravastatin and cholestyramine alone and combined in patients with hypercholesterolemia. Pravastatin Multicenter Study Group II.
    Arch Intern Med; 1993 Jun; 153(11):1321-9. PubMed ID: 8507122
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Probucol treatment decreases serum concentrations of diet-derived antioxidants.
    Elinder LS; Hådell K; Johansson J; Mølgaard J; Holme I; Olsson AG; Walldius G
    Arterioscler Thromb Vasc Biol; 1995 Aug; 15(8):1057-63. PubMed ID: 7627696
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Time-dependent change in the effect of probucol in subjects with elevated cholesterol.
    Fujimura A; Ohashi K; Ebihara A
    Eur J Clin Pharmacol; 1992; 43(3):299-301. PubMed ID: 1425896
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lovastatin: cholesterol-lowering agent.
    DiPalma JR
    Am Fam Physician; 1987 Dec; 36(6):189-92. PubMed ID: 3687679
    [No Abstract]   [Full Text] [Related]  

  • 18. The relation of coronary and peripheral arterial disease to the severity of femoral atherosclerosis in hypercholesterolaemia.
    Bergstrand L; Olsson AG; Erikson U; Holme I; Johansson J; Kaijser L; Lassvik C; Mölgaard J; Nilsson S; Stenport G
    J Intern Med; 1994 Oct; 236(4):367-75. PubMed ID: 7931039
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effectiveness of probucol in reducing plasma low-density lipoprotein cholesterol oxidation in hypercholesterolemia.
    Masana L; Bargalló MT; Plana N; LaVille A; Casals I; Solà R
    Am J Cardiol; 1991 Oct; 68(9):863-7. PubMed ID: 1927944
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Controlled studies of the efficacy and safety of combined probucol-colestipol therapy.
    Dujovne CA; Krehbiel P; Chernoff SB
    Am J Cardiol; 1986 Jun; 57(16):36H-42H. PubMed ID: 3524176
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.